Inventera Inc. (KOSDAQ:0007J0)

Market Cap	83.38B
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	7.87M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	64,508
Open	10,890
Previous Close	11,270
Day's Range	10,330 - 11,470
52-Week Range	10,600 - 60,200
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Inventera

Inventera Inc. operates as a biotechnology company specializing in the development of MRI contrast agents. The company offers nanoparticle-based platforms, designed to enhance both the resolution and safety of MRI. The company develops contrast agents targeting the articular system, lymphatic vessels, and the pancreatic and biliary systems. Inventera Inc. was incorporated in 2018 and is based in Seoul, South Korea.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2018
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 0007J0